INSP Stock Recent News

Inspire (INSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MINNEAPOLIS, April 04, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2023 after the close of trading on Tuesday, May 2. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

These articles are intended to provide readers with equity investment subjects [stocks, ETFs, REITs] likely to experience rising market prices in the next 3-5 months: Near-term expectations only. Histories of their prior expectations -- like today's for INSP coming price outcomes -- are presented for stocks frequently Yahoo-sourced by investors at the same time.

MINNEAPOLIS, March 07, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023.

Inspire is Wednesday's IBD Stock Of The Day. The sleep apnea expert reported massive sales growth, leading shares to break out.

Inspire Medical Systems, Inc. (NYSE:INSP ) Q4 2022 Results Conference Call February 7, 2023 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Robbie Marcus - JPMorgan Adam Maeder - Piper Sandler Rich Newitter - Truist Larry Biegelsen - Wells Fargo John Block - Stifel Michael Polark - Wolfe Research Chris Pasquale - Nephron Research Matthew Mishan - KeyBanc Suraj Kalia - Oppenheimer Operator Good afternoon. My name is Josh, and I'll be your conference operator today.

Inspire (INSP) delivered earnings and revenue surprises of 118.52% and 0.14%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Market-makers then told us INSP stock price could likely grow +20% in 6 weeks, as it had 39 times in previous four years. Wrong: it only took 3 weeks. Now they're back with a calmer story of only +16% gain in 6 weeks, but point to twice as many gains of that size, anticipated in the last 4 years.

MINNEAPOLIS, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and fiscal 2022 after the close of trading on Tuesday, February 7. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.